Home Latest News Why Nipah Virus Has a High Fatality Rate: Factors Affecting Disease Severity
Latest News

Why Nipah Virus Has a High Fatality Rate: Factors Affecting Disease Severity

Share
The Nipah virus is considered one of the deadliest zoonotic infections globally, not because it spreads rapidly like influenza or COVID-19, but because of its extremely high fatality rate, rapid progression, and severe brain involvement. Medical experts warn that once symptoms escalate, the disease can turn fatal within days. According to available data, the case fatality rate of Nipah virus ranges between 50 and 75 per cent, placing it among the most lethal viral infections known to humans. In this explainer, Dr Dip Narayan Mukherjee, Consultant – Microbiology and Infectious Diseases, CK Birla Hospitals, CMRI, sheds light on why the virus is so dangerous and difficult to control. Why Is the Nipah Virus So Deadly? According to Dr Mukherjee, Nipah’s lethality lies in a combination of delayed symptom recognition, aggressive disease progression, and early involvement of the brain. “Nipah virus often begins with very non-specific symptoms, which makes early detection difficult. By the time it is clinically suspected, the virus may have already affected the brain,” he explains. Early Symptoms Often Go Unnoticed One of the biggest challenges in controlling Nipah virus is that its initial symptoms closely resemble common viral illnesses, leading to delays in diagnosis and isolation. Early symptoms include: Fever Headache Cough Muscle pain General weakness “These symptoms are easily mistaken for flu, viral fever, or respiratory infections,” says Dr Mukherjee. “This delay gives the virus time to progress silently.” Severe Brain Infection Drives High Mortality The most dangerous aspect of Nipah virus infection is its neurological involvement. The virus frequently causes encephalitis, or inflammation of the brain, which significantly increases the risk of death. Neurological symptoms may include: Seizures Confusion and altered consciousness Extreme drowsiness Coma “Once the central nervous system is involved, the disease becomes very difficult to manage,” Dr Mukherjee notes. “At this stage, treatment is largely supportive because there is no specific antiviral therapy available.” This lack of targeted treatment options makes early detection critical. Human-to-Human Transmission Raises Risk While Nipah virus is primarily transmitted from fruit bats, it can also spread from person to person, particularly in healthcare settings. Dr Mukherjee points out that: Caregivers and healthcare workers are at higher risk Exposure to high viral loads can worsen outcomes Inadequate infection control increases transmission risk “Strict adherence to infection control practices is essential. Even a small lapse can result in secondary infections,” he says. Zoonotic Nature Makes Exposure Hard to Predict Nipah virus is transmitted from fruit bats, either directly or through intermediate hosts such as pigs. This zoonotic pattern makes outbreaks unpredictable, especially in regions where humans, animals, and wildlife interact closely. Adding to the challenge: There is no approved vaccine Treatment options remain limited Isolation protocols must be strictly enforced What Can Reduce Nipah Fatalities? According to experts, early action remains the most effective defence against Nipah virus. Key measures include: Early isolation of suspected cases Strict use of personal protective equipment (PPE) Rapid escalation and referral to specialised centres Strong hospital infection control protocols “The earlier the virus is identified and contained, the better the chances of preventing severe disease and fatalities,” Dr Mukherjee emphasises. The Bottom Line Nipah virus continues to be a serious public health threat because of its high fatality rate, neurological complications, and lack of targeted treatment. Its ability to masquerade as a mild illness in the early stages makes vigilance crucial. Health experts stress that awareness, early suspicion, and strict infection control are currently the most powerful tools to reduce deaths linked to this deadly virus. As Dr Mukherjee concludes, “With Nipah, time is the most critical factor. Early recognition can save lives.”
The Nipah virus is considered one of the deadliest zoonotic infections globally, not because it spreads rapidly like influenza or COVID-19, but because of its extremely high fatality rate, rapid progression, and severe brain involvement. Medical experts warn that once symptoms escalate, the disease can turn fatal within days. According to available data, the case fatality rate of Nipah virus ranges between 50 and 75 per cent, placing it among the most lethal viral infections known to humans. In this explainer, Dr Dip Narayan Mukherjee, Consultant – Microbiology and Infectious Diseases, CK Birla Hospitals, CMRI, sheds light on why the virus is so dangerous and difficult to control. Why Is the Nipah Virus So Deadly? According to Dr Mukherjee, Nipah’s lethality lies in a combination of delayed symptom recognition, aggressive disease progression, and early involvement of the brain. “Nipah virus often begins with very non-specific symptoms, which makes early detection difficult. By the time it is clinically suspected, the virus may have already affected the brain,” he explains. Early Symptoms Often Go Unnoticed One of the biggest challenges in controlling Nipah virus is that its initial symptoms closely resemble common viral illnesses, leading to delays in diagnosis and isolation. Early symptoms include: Fever Headache Cough Muscle pain General weakness “These symptoms are easily mistaken for flu, viral fever, or respiratory infections,” says Dr Mukherjee. “This delay gives the virus time to progress silently.” Severe Brain Infection Drives High Mortality The most dangerous aspect of Nipah virus infection is its neurological involvement. The virus frequently causes encephalitis, or inflammation of the brain, which significantly increases the risk of death. Neurological symptoms may include: Seizures Confusion and altered consciousness Extreme drowsiness Coma “Once the central nervous system is involved, the disease becomes very difficult to manage,” Dr Mukherjee notes. “At this stage, treatment is largely supportive because there is no specific antiviral therapy available.” This lack of targeted treatment options makes early detection critical. Human-to-Human Transmission Raises Risk While Nipah virus is primarily transmitted from fruit bats, it can also spread from person to person, particularly in healthcare settings. Dr Mukherjee points out that: Caregivers and healthcare workers are at higher risk Exposure to high viral loads can worsen outcomes Inadequate infection control increases transmission risk “Strict adherence to infection control practices is essential. Even a small lapse can result in secondary infections,” he says. Zoonotic Nature Makes Exposure Hard to Predict Nipah virus is transmitted from fruit bats, either directly or through intermediate hosts such as pigs. This zoonotic pattern makes outbreaks unpredictable, especially in regions where humans, animals, and wildlife interact closely. Adding to the challenge: There is no approved vaccine Treatment options remain limited Isolation protocols must be strictly enforced What Can Reduce Nipah Fatalities? According to experts, early action remains the most effective defence against Nipah virus. Key measures include: Early isolation of suspected cases Strict use of personal protective equipment (PPE) Rapid escalation and referral to specialised centres Strong hospital infection control protocols “The earlier the virus is identified and contained, the better the chances of preventing severe disease and fatalities,” Dr Mukherjee emphasises. The Bottom Line Nipah virus continues to be a serious public health threat because of its high fatality rate, neurological complications, and lack of targeted treatment. Its ability to masquerade as a mild illness in the early stages makes vigilance crucial. Health experts stress that awareness, early suspicion, and strict infection control are currently the most powerful tools to reduce deaths linked to this deadly virus. As Dr Mukherjee concludes, “With Nipah, time is the most critical factor. Early recognition can save lives.”
Share

The Nipah virus is widely regarded as one of the deadliest zoonotic infections known to humans. With reported fatality rates ranging from 50 to 75 percent, the virus poses a serious public health threat, particularly in parts of South and Southeast Asia where outbreaks have occurred repeatedly. Experts say its high mortality is driven by a combination of delayed diagnosis, rapid disease progression, and severe neurological complications.

One of the biggest challenges in controlling Nipah virus infection is its subtle and misleading onset. The disease often begins with common, non-specific symptoms such as fever, headache, muscle pain, cough, and general fatigue. These early signs closely resemble routine viral illnesses, including influenza or seasonal infections.

Because of this, patients may not seek immediate medical attention, and healthcare providers may not initially suspect Nipah virus. By the time the infection is identified, the virus may have already advanced significantly, reducing the chances of successful intervention.

Neurological involvement is a defining and dangerous feature of Nipah virus infection. The virus frequently causes encephalitis, an inflammation of the brain that leads to seizures, altered consciousness, confusion, extreme drowsiness, coma, and often death.

Once the central nervous system is affected, treatment options become extremely limited. There is currently no specific antiviral therapy approved for Nipah virus, and care is largely supportive—focused on managing symptoms and preventing complications. This lack of targeted treatment is a major reason behind the virus’s high fatality rate.

Human-to-Human Transmission Raises Risk

Another critical factor contributing to disease severity is human-to-human transmission, particularly in healthcare and caregiving settings. Close contact with infected patients, especially without proper infection control measures, can result in exposure to high viral loads.

Healthcare workers and family caregivers are often at increased risk, and repeated exposure may worsen disease outcomes. Inadequate use of personal protective equipment (PPE) and delayed isolation can accelerate the spread within hospitals and communities.

Zoonotic Nature and Absence of a Vaccine

Nipah virus is transmitted from fruit bats, either directly or through intermediary hosts such as pigs. This unpredictable mode of transmission makes it difficult to anticipate outbreaks and control exposure. Contaminated fruits, raw date palm sap, or close contact with infected animals have all been linked to past cases.

Compounding the problem is the absence of a licensed vaccine for Nipah virus. Strict isolation protocols, contact tracing, and community awareness remain the primary tools for outbreak management, but these measures are resource-intensive and challenging to sustain during widespread outbreaks.

Expert View: Early Action Is Key to Saving Lives

According to Dr. Dip Narayan Mukherjee, Consultant – Microbiology and Infectious Diseases at CK Birla Hospitals, CMRI, early recognition and containment remain the most effective strategies to reduce fatalities.

He emphasise early isolation, strict use of PPE, and rapid escalation of suspected cases as critical steps in lowering mortality. The earlier the virus is identified and contained, the better the chances of preventing severe disease and deaths.

Nipah virus’s high fatality rate is not due to a single factor, but rather a deadly combination of delayed symptom recognition, aggressive neurological involvement, human-to-human transmission, and the lack of specific treatment or vaccination. Strengthening surveillance, improving awareness among healthcare workers, and ensuring rapid isolation of suspected cases are essential to preventing future fatalities.

As experts warn, preparedness—not panic—is the strongest defence against one of the world’s most lethal viruses.

Share
Written by
Satata Karmakar

Satata Karmakar is a health journalist and Editor of HealthWireMedia.com, with over 12 years of experience in journalism, investigative reporting, newsroom editing and healthcare news. As Editor of HealthWire Media, Satata focuses on delivering accurate, evidence-based and accessible health journalism that helps readers make sense of complex medical and healthcare developments. She specialises in translating medical research, clinical findings, public-health updates and healthcare regulations into clear, engaging stories for healthcare professionals and the wider public. Her areas of coverage include public health, medical research, disease prevention, healthcare policy, health technology, medical education and regulatory developments. She places particular emphasis on verifying health claims through peer-reviewed research, official government notifications, expert interviews and credible institutional sources, including the National Medical Commission (NMC). She is committed to responsible health reporting that prioritises accuracy, context and transparency—especially when covering emerging research, medical breakthroughs, health risks and treatment-related information. Her editorial approach aims to make reliable health information understandable without oversimplifying science or overstating medical claims. Through her work, she seeks to strengthen public understanding of healthcare issues and contribute to informed conversations around health, medicine and policy. Outside the newsroom, Satata enjoys reading and painting, pursuits that continue to inspire her curiosity, creativity and storytelling.

Don't Miss

Bundibugyo Ebola virus
International NewsVirus & DiseaseWHO

From Fever To Organ Failure: How The Bundibugyo Ebola Virus Affects The Body

The Bundibugyo Ebola virus outbreak has raised fresh global health concerns as infections continue to spread across parts of Central and East Africa....

WHO
Health TipsInternational NewsLatest NewsLifestyle & WellnessWHO

WHO Issues First Type 1 Diabetes Guidelines for Adults: 7 Things Patients Need to Know

More than 100 years after the discovery of insulin, millions of people living with type 1 diabetes continue to face challenges in accessing...

Breast Cancer
Health NewsOncology

Mammogram vs Ultrasound vs MRI: Which Breast Cancer Screening Test Is Right for You?

Breast cancer is one of the most common cancers affecting women worldwide, and early detection plays an important role in improving treatment outcomes....

Always Tired? It Could Be Anaemia!
Diet & NutritionHealth NewsHealth TipsLifestyleLifestyle & WellnessWellness

Anaemia in India: Why Iron Deficiency Remains a Concern and 7 Signs You Should Not Ignore

Feeling tired all the time, experiencing frequent dizziness or getting breathless after climbing a few stairs? While these symptoms are often dismissed as...

N95 Mask
Health TipsLatest NewsLifestyle & WellnessWellness

Does Wearing an N95 Mask Protect You From PM2.5 Pollution? Doctors Explain How To Choose And Wear It Correctly

As air pollution continues to affect several Indian cities during winter, wearing a mask has become an important precaution for people stepping outdoors....

Section title

Related Articles
Latest NewsWHO

WHO Releases First-Ever Guidelines For Type 1 Diabetes In Adults: 5 Key Recommendations Explained

The World Health Organization (WHO) has issued its first-ever guidelines for the...

Health NewsLatest NewsLifestyle

7 Simple Ways to Protect Yourself from Air Pollution

Air pollution has become a major health concern today. Dust from construction...